Trial
NCT00718328
Simvastatin For Intracerebral Hemorrhage Study
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Johns Hopkins University
Collaborators
National Center for Research Resources (NCRR); National Institutes of Health (NIH)
Condition
Intracerebral Hemorrhage
Intervention
Simvastatin 80 mg
Why stopped
Poor recruitment, trial terminated
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-10-09